WallStreetZenWallStreetZen

NASDAQ: MDGS
Medigus Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MDGS past revenue growth

How has MDGS's revenue growth performed historically?
Company
96.44%
Industry
5.93%
Market
13.73%
MDGS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MDGS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MDGS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MDGS earnings and revenue history

Current Revenue
$83.5M
Current Earnings
-$14.6M
Current Profit Margin
-17.5%

MDGS Return on Equity

Current Company
-38%
Current Industry
7.1%
Current Market
-0.3%
MDGS's Return on Equity (-38%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MDGS announces earnings.

MDGS Return on Assets

Current Company
-16.2%
Current Industry
4.4%
MDGS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MDGS Return on Capital Employed

Current Company
-24.13%
Current Industry
7.5%
MDGS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MDGS vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MDGS$83.45MN/A-$14.60M+192.16%N/A
NURO$7.20M-$5.37M-$5.41M-15.97%N/A
VVOS$15.45M-$18.33M-$18.75M+3.06%N/A
AEMD$574.25k-$12.09M-$12.41M+13.92%N/A
HSDT$845.00k-$9.15M-$10.06M-15.70%N/A
View Top Medical Device Stocks

Medigus Earnings & Revenue FAQ

What were MDGS's earnings last quarter?

Medigus (NASDAQ: MDGS) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Medigus earnings for the quarter were N/A. In the same quarter last year, Medigus's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Medigus stock.

What was MDGS's earnings growth in the past year?

As of Q4 2023, Medigus's earnings has grown year over year. Medigus's earnings in the past year totalled -$14.60 million.

What was MDGS's revenue last quarter?

Medigus (NASDAQ: MDGS) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Medigus's revenue was N/A.

What was MDGS's revenue growth in the past year?

As of Q4 2023, Medigus's revenue has grown 96.44% year over year. This is 90.51 percentage points higher than the US Medical Devices industry revenue growth rate of 5.93%. Medigus's revenue in the past year totalled $83.45 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.